Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-15-245098
Filing Date
2015-07-06
Accepted
2015-07-06 11:20:59
Documents
2
Period of Report
2015-07-06

Document Format Files

Seq Description Document Type Size
1 6-K d67136d6k.htm 6-K 8663
2 EX-1 d67136dex991.htm EX-99.1 8564
  Complete submission text file 0001193125-15-245098.txt   18240
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-37410 | Film No.: 15972462
SIC: 2834 Pharmaceutical Preparations